Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial - Brunner, HI; Ruperto, N; Tzaribachev, N (Ann Rheum Dis, 2017)
et al.